BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 25148681)

  • 1. Therapeutic molecules and endogenous ligands regulate the interaction between brain cellular prion protein (PrPC) and metabotropic glutamate receptor 5 (mGluR5).
    Haas LT; Kostylev MA; Strittmatter SM
    J Biol Chem; 2014 Oct; 289(41):28460-77. PubMed ID: 25148681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Amyloid β Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex.
    Beraldo FH; Ostapchenko VG; Caetano FA; Guimaraes AL; Ferretti GD; Daude N; Bertram L; Nogueira KO; Silva JL; Westaway D; Cashman NR; Martins VR; Prado VF; Prado MA
    J Biol Chem; 2016 Oct; 291(42):21945-21955. PubMed ID: 27563063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligomers of Amyloid β Prevent Physiological Activation of the Cellular Prion Protein-Metabotropic Glutamate Receptor 5 Complex by Glutamate in Alzheimer Disease.
    Haas LT; Strittmatter SM
    J Biol Chem; 2016 Aug; 291(33):17112-21. PubMed ID: 27325698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein.
    Um JW; Kaufman AC; Kostylev M; Heiss JK; Stagi M; Takahashi H; Kerrisk ME; Vortmeyer A; Wisniewski T; Koleske AJ; Gunther EC; Nygaard HB; Strittmatter SM
    Neuron; 2013 Sep; 79(5):887-902. PubMed ID: 24012003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silent Allosteric Modulation of mGluR5 Maintains Glutamate Signaling while Rescuing Alzheimer's Mouse Phenotypes.
    Haas LT; Salazar SV; Smith LM; Zhao HR; Cox TO; Herber CS; Degnan AP; Balakrishnan A; Macor JE; Albright CF; Strittmatter SM
    Cell Rep; 2017 Jul; 20(1):76-88. PubMed ID: 28683325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion-Protein-interacting Amyloid-β Oligomers of High Molecular Weight Are Tightly Correlated with Memory Impairment in Multiple Alzheimer Mouse Models.
    Kostylev MA; Kaufman AC; Nygaard HB; Patel P; Haas LT; Gunther EC; Vortmeyer A; Strittmatter SM
    J Biol Chem; 2015 Jul; 290(28):17415-38. PubMed ID: 26018073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid and Hydrogel Phases of PrP
    Kostylev MA; Tuttle MD; Lee S; Klein LE; Takahashi H; Cox TO; Gunther EC; Zilm KW; Strittmatter SM
    Mol Cell; 2018 Nov; 72(3):426-443.e12. PubMed ID: 30401430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic and standardized comparison of reported amyloid-β receptors for sufficiency, affinity, and Alzheimer's disease relevance.
    Smith LM; Kostylev MA; Lee S; Strittmatter SM
    J Biol Chem; 2019 Apr; 294(15):6042-6053. PubMed ID: 30787106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular prion protein as a receptor for amyloid-β oligomers in Alzheimer's disease.
    Salazar SV; Strittmatter SM
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1143-1147. PubMed ID: 27639648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prion protein ligand, stress-inducible phosphoprotein 1, regulates amyloid-β oligomer toxicity.
    Ostapchenko VG; Beraldo FH; Mohammad AH; Xie YF; Hirata PH; Magalhaes AC; Lamour G; Li H; Maciejewski A; Belrose JC; Teixeira BL; Fahnestock M; Ferreira ST; Cashman NR; Hajj GN; Jackson MF; Choy WY; MacDonald JF; Martins VR; Prado VF; Prado MA
    J Neurosci; 2013 Oct; 33(42):16552-64. PubMed ID: 24133259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aβ oligomers induce pathophysiological mGluR5 signaling in Alzheimer's disease model mice in a sex-selective manner.
    Abd-Elrahman KS; Albaker A; de Souza JM; Ribeiro FM; Schlossmacher MG; Tiberi M; Hamilton A; Ferguson SSG
    Sci Signal; 2020 Dec; 13(662):. PubMed ID: 33323410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide aptamer targeting Aβ-PrP-Fyn axis reduces Alzheimer's disease pathologies in 5XFAD transgenic mouse model.
    Ali T; Klein AN; Vu A; Arifin MI; Hannaoui S; Gilch S
    Cell Mol Life Sci; 2023 May; 80(6):139. PubMed ID: 37149826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-PrP
    Cox TO; Gunther EC; Brody AH; Chiasseu MT; Stoner A; Smith LM; Haas LT; Hammersley J; Rees G; Dosanjh B; Groves M; Gardener M; Dobson C; Vaughan T; Chessell I; Billinton A; Strittmatter SM
    Ann Clin Transl Neurol; 2019 Mar; 6(3):554-574. PubMed ID: 30911579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.
    Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M
    Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncanonical Metabotropic Glutamate Receptor 5 Signaling in Alzheimer's Disease.
    Abd-Elrahman KS; Ferguson SSG
    Annu Rev Pharmacol Toxicol; 2022 Jan; 62():235-254. PubMed ID: 34516293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synaptotoxic Signaling by Amyloid Beta Oligomers in Alzheimer's Disease Through Prion Protein and mGluR5.
    Brody AH; Strittmatter SM
    Adv Pharmacol; 2018; 82():293-323. PubMed ID: 29413525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of group-I metabotropic glutamate receptors protects against prion toxicity.
    Goniotaki D; Lakkaraju AKK; Shrivastava AN; Bakirci P; Sorce S; Senatore A; Marpakwar R; Hornemann S; Gasparini F; Triller A; Aguzzi A
    PLoS Pathog; 2017 Nov; 13(11):e1006733. PubMed ID: 29176838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Domains of STIP1 responsible for regulating PrPC-dependent amyloid-β oligomer toxicity.
    Maciejewski A; Ostapchenko VG; Beraldo FH; Prado VF; Prado MA; Choy WY
    Biochem J; 2016 Jul; 473(14):2119-30. PubMed ID: 27208175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabotropic glutamate receptors transduce signals for neurite outgrowth after binding of the prion protein to laminin γ1 chain.
    Beraldo FH; Arantes CP; Santos TG; Machado CF; Roffe M; Hajj GN; Lee KS; Magalhães AC; Caetano FA; Mancini GL; Lopes MH; Américo TA; Magdesian MH; Ferguson SS; Linden R; Prado MA; Martins VR
    FASEB J; 2011 Jan; 25(1):265-79. PubMed ID: 20876210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease.
    Crestini A; Santilli F; Martellucci S; Carbone E; Sorice M; Piscopo P; Mattei V
    J Alzheimers Dis; 2022; 85(2):503-518. PubMed ID: 34864675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.